Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Infect Dis ; 186(1): 64-73, 2002 Jul 01.
Article in English | MEDLINE | ID: mdl-12089663

ABSTRACT

Pseudomonas aeruginosa is a gram-negative pathogen causing life-threatening infections. Lung injury and the development of sepsis depend largely on the expression of type III secretion system (TTSS) virulence. TTSS functions as a molecular syringe to deliver toxins directly to the cytosol of cells, inhibit innate immune mechanisms, and prevent bacterial clearance. Polyclonal antibodies that bind to PcrV of P. aeruginosa inhibit the delivery of type III toxins and enhance the clearance of bacteria during acute lung infections. PcrV is a homologue of LcrV, a protective antigen in the Yersinia TTSS and an integral component of TTSS. In this study, a murine monoclonal antibody (MAb) to PcrV was generated: MAb 166, which is protective against P. aeruginosa when coinstilled with the bacterial inoculum or intraperitoneally transferred to mice. Fab fragments from MAb 166 prevent sepsis and death. The epitope bound by MAb 166 was mapped to the carboxyl-terminus of PcrV.


Subject(s)
Antibodies, Bacterial/biosynthesis , Antibodies, Monoclonal/biosynthesis , Antigens, Bacterial/immunology , Bacterial Toxins/immunology , Pseudomonas Infections/drug therapy , Pseudomonas aeruginosa/immunology , Animals , Antibodies, Bacterial/therapeutic use , Antibodies, Monoclonal/therapeutic use , Disease Models, Animal , Epitope Mapping , Immunoglobulin Fab Fragments/therapeutic use , Male , Mice , Mice, Inbred BALB C , Pore Forming Cytotoxic Proteins , Pseudomonas Infections/mortality , Sepsis/drug therapy , Sepsis/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL
...